MedLife S.A.

Report Publication Announcement • Jan 23, 2025

To: BUCHAREST STOCK EXCHANGE FINANCIAL SUPERVISORY AUTHORITY

CURRENT REPORT

Current report drafted according to the stipulations of ASF Regulation no. 5/2018 on issuers of financial instruments and market operations, Law no. 24/2017 on issuers of financial instruments and market operations, and the provisions of Article 92 paragraph (1) of Section 2, Chapter VI, Title II Issuers and Financial Instruments of the Code of the Bucharest Stock Exchange

Report Date: 23 January 2025

Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")

Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania

Telephone / Fax number: 0374 180 470

Unique Registration Code at the National Office of Trade Registry: 8422035

Order number on the Trade Registry: J40/3709/1996

Subscribed and paid-in share capital: 132,870,492 RON

Total number of shares: 531,481,968 (out of which 427,042 shares without voting rights and 531,054,926 shares with voting rights)

Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Significant events to report:

2025 Financial Calendar

EVENT	DATE
Publication of the 2024 Preliminary Unaudited Annual Financial Results	28 February 2025
Conference Call for the 2024 Preliminary Unaudited Annual Financial Results	28 February 2025
Annual General Shareholders Meeting	29 April 2025
Publication of the 2024 Annual Report	30 April 2025
Publication of the Q1 2025 Results Report	15 May 2025
Conference Call for the Q1 2025 Results Report	15 May 2025
Publication of the H1 2025 Results Report	29 August 2025
Conference Call for the H1 2025 Results Report	29 August 2025
Publication of the Q3 2025 Results Report	14 November 2025
Conference Call for the Q3 2025 Results Report	14 November 2025

______________